CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02171 CARSGEN-B

Market Closed 04-24 16:08:27

24.700

+0.900

+3.78%

High24.960	Low23.240	Vol4.50M
Open23.800	D1 Closing23.800	Amplitude7.23%
Mkt Cap14.08B	Tradable Cap14.08B	Total Shares570.00M
T/O109.48M	T/O Rate0.79%	Tradable Shares570.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"CARSGEN-B","latestPrice":24.7,"timestamp":1777018107004,"preClose":23.8,"halted":0,"volume":4503000,"delay":0,"changeRate":0.03781512605042011,"floatShares":570000000,"shares":570000000,"eps":-0.20323092169061757,"marketStatus":"Market Closed","change":0.9,"latestTime":"04-24 16:08:27","open":23.8,"high":24.96,"low":23.24,"amount":109478679,"amplitude":0.072269,"askPrice":24.78,"askSize":2000,"bidPrice":24.7,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":-0.20323092169061757,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":7,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":23.8,"openAndCloseTimeList":[[1776994200000,1777003200000],[1777006800000,1777017600000]],"volumeRatio":0.5661803182314806,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171","defaultTab":"news","newsList":[{"id":"1156253477","title":"Stock Track | CARSGEN-B Plummets 5.04% Intraday on Profit-Taking After Lancet Publication Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1156253477","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156253477?lang=en_us&edition=fundamental","pubTime":"2026-04-22 10:31","pubTimestamp":1776825083,"startTime":"0","endTime":"0","summary":"CARSGEN-B's stock price fell sharply intraday, declining by 5.04%. The movement represents a continuation of a downward trend following a significant rally earlier in the week.Market analysis...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102592704","title":"Stock Track | CARSGEN-B Soars 10.92% Intraday as CAR-T Therapy Research Published in The Lancet","url":"https://stock-news.laohu8.com/highlight/detail?id=1102592704","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102592704?lang=en_us&edition=fundamental","pubTime":"2026-04-20 09:40","pubTimestamp":1776649210,"startTime":"0","endTime":"0","summary":"CARSGEN-B's stock price surged 10.92% during intraday trading on Monday. The significant upward movement reflects a sharp increase in investor confidence following a major scientific development for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129844134","title":"CARSGEN-B 2025年业绩：收入约1.2566亿元，净亏损显著收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=1129844134","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129844134?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:27","pubTimestamp":1775827639,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited（下称“CARSGEN-B”，香港联交所股份代号：02171）于2025财政年度实现收入约人民币1.2566亿元，主要来自获批上市的自体BCMA CAR T细胞产品zevorcabtagene...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136777751","title":"CARsgen reiterates shift to electronic dissemination of corporate communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1136777751","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136777751?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:23","pubTimestamp":1775827404,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited issued a reminder that it has fully adopted electronic dissemination for all future corporate communications. English and Chinese versions of documents such as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165606673","title":"CARsgen Adopts Full Electronic Dissemination of Corporate Communications, Seeks Shareholders’ Email Addresses","url":"https://stock-news.laohu8.com/highlight/detail?id=1165606673","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165606673?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:21","pubTimestamp":1775827266,"startTime":"0","endTime":"0","summary":"On 10 April 2026, CARsgen Therapeutics Holdings Limited issued a reminder confirming the transition to electronic dissemination of all corporate communications. The company will provide printed...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626711847","title":"CARsgen publishes shareholder reminder on electronic corporate communications dissemination arrangement","url":"https://stock-news.laohu8.com/highlight/detail?id=2626711847","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626711847?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:10","pubTimestamp":1775826602,"startTime":"0","endTime":"0","summary":"CARsgen issued reminder to non-registered shareholders on electronic dissemination of corporate communications, with documents available on www.carsgen.com.Notice dated April 10, 2026 reiterated printed corporate communications will be provided only on request.Non-registered holders were urged to provide valid email addresses to banks, brokers, custodians, nominees, or HKSCC Nominees through which shares are held.Printed copies can be requested by submitting reply form to share registrar.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 10, 2026, an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDL1Ry0cq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02171","BK1587","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626181781","title":"CARsgen Therapeutics announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2626181781","media":"Reuters","labels":["conferences","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626181781?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:08","pubTimestamp":1775826534,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics will hold its annual general meeting in Shanghai on May 22, 2026.Shareholders will vote on adoption of audited consolidated financial statements for year ended Dec. 31, 2025.Ballots will cover re-election of executive directors Zonghai Li, Huamao Wang, Hua Jiang.Items include mandates to issue shares or sell or transfer treasury shares up to 20%, repurchase shares up to 10%.Meeting will also vote on reappointment of Ernst & Young as auditor, director remuneration, amendments to memorandum and articles of association.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLbx2vHg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1587","02171","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626118117","title":"CARsgen publishes 2025 annual report, posts RMB 125.7 million revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2626118117","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626118117?lang=en_us&edition=fundamental","pubTime":"2026-04-10 21:07","pubTimestamp":1775826431,"startTime":"0","endTime":"0","summary":"CARsgen annual report for 2025 flagged a shift into value realization, led by stronger commercialization of BCMA CAR-T zevorcabtagene autoleucel.Huadong Medicine placed 218 confirmed orders for zevor-cel during 2025.Claudin18.2 CAR-T satricabtagene autoleucel entered China NDA review in June 2025, with approval expected in first half of 2026.Strategy pivot accelerated toward off-the-shelf allogeneic CAR-T, with CT0596 and CT1190B positioned for IND clearance and Phase Ib trial starts in 2026 in China.Manufacturing footprint expanded in Shanghai, with a new Jinshan commercial base planned under a project capped at RMB 370 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260410:nNDLch6MLc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","000963","BK0187","BK0209","BK1587","BK0175","02171","BK1585","LU1969619763.USD","LU2328871848.SGD","BK0132","BK0183","BK1574","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168870926","title":"CARsgen Adds 40,500 New Shares in March; Issues 4.27 Million Options While Maintaining Public Float","url":"https://stock-news.laohu8.com/highlight/detail?id=1168870926","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168870926?lang=en_us&edition=fundamental","pubTime":"2026-04-09 19:04","pubTimestamp":1775732683,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited reported a net increase of 40,500 ordinary shares for March 2026, lifting its issued share count (excluding treasury stock) to 570.35 million. Treasury shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620222709","title":"Assessing CARsgen Therapeutics Holdings’s Valuation After Full Year 2025 Results And Narrowed Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2620222709","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620222709?lang=en_us&edition=fundamental","pubTime":"2026-03-19 23:05","pubTimestamp":1773932711,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) moved after releasing full year 2025 results, reporting sales of CN¥125.66 million and a net loss of CN¥97.86 million, along with updated corporate governance proposals announced the same day.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe earnings release and governance proposals arrived after a firm 27.64% 1 year total shareholder return. The 30 day and 90 day share price returns of 4.18% and 4.67% suggest momentum has been building...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdingss-valuation-after-ful","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/assessing-carsgen-therapeutics-holdingss-valuation-after-ful","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02171","LENZ","BK1161","BK1587","BK1585","BK1574","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618920784","title":"CARsgen Therapeutics Holdings SEHK 2171 Valuation After Stronger 2025 Results And Narrowed Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2618920784","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618920784?lang=en_us&edition=fundamental","pubTime":"2026-03-12 00:35","pubTimestamp":1773246927,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) has drawn attention after reporting full year 2025 earnings, with sales of CNY 125.66 million, a net loss of CNY 97.86 million, and basic loss per share of CNY 0.18.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nThe earnings update appears to have coincided with a sharp shift in sentiment, with a 42.97% 7 day share price return and a 17.85% 30 day share price return at HK$16.37. Meanwhile, the 1 year total shareholder return of 14.16% and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk-2171-valuation-after-stro","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk-2171-valuation-after-stro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1585","BK4007","LENZ","BK4139","BK1574","BK4539","BK1161","02171","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106814148","title":"Stock Track | CARSGEN-B Soars 11.71% Intraday on Robust Annual Results and Stock Connect Inclusion","url":"https://stock-news.laohu8.com/highlight/detail?id=1106814148","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106814148?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:31","pubTimestamp":1773109870,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) surged 11.71% during intraday trading on Tuesday, extending recent gains for the biotechnology company.The sharp rise follows the company's release of strong annual results, which...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118317633","title":"CARSGEN-B Shares Surge Over 12% Following Strong Annual Revenue Growth and Inclusion in Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=1118317633","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118317633?lang=en_us&edition=fundamental","pubTime":"2026-03-10 10:24","pubTimestamp":1773109461,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) rose more than 12%, extending its recent gains. At the time of writing, the stock was up 10.78% to HK$15.42, with a turnover of HK$127 million. The company recently released its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK4585","VXUS","BK4588","02171","BK1574","BK1161","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618244696","title":"CARsgen Therapeutics grants 4.27 million share options under post-IPO scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2618244696","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618244696?lang=en_us&edition=fundamental","pubTime":"2026-03-09 22:08","pubTimestamp":1773065332,"startTime":"0","endTime":"0","summary":"CARsgen granted 4.27 million share options to 181 grantees under its post-IPO share option scheme. The options have an exercise price of HKD 13.92 per share and require HKD 1 consideration per grantee upon acceptance. Separately, CARsgen granted 3.31 million restricted share units to 178 grantees under its 2019 equity incentive plan. The RSUs have nil consideration and nil purchase price. Both the options and RSUs vest 25% annually from March 9, 2027 through March 9, 2030.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 09, 2026, and is solely resp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL4bd0tF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02171","BK1587","BK1161","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618616952","title":"BUZZ-CARsgen Therapeutics jumps most on record as full-year losses narrow","url":"https://stock-news.laohu8.com/highlight/detail?id=2618616952","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618616952?lang=en_us&edition=fundamental","pubTime":"2026-03-09 11:20","pubTimestamp":1773026430,"startTime":"0","endTime":"0","summary":"BUZZ-CARsgen Therapeutics jumps most on record as full-year losses narrow** Shares of CARsgen Therapeutics Holdings 2171.HK jump as much as 42.6% to HK$15.50, their biggest intraday pct gain since debut in June 2021 ** Stock hits its highest level since February 26** The Chinese cell therapies developer says its 2025 net loss narrowed to 103 million yuan , from 798 million yuan loss in 2024, due to decrease in research and development, and administrative expenses, among others** YTD, stock down 7.6%, Hang Seng Biotech Index .HSBIO down 1.8%  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nL1N3ZX03H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1587","02171","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114135542","title":"CARSGEN-B Surges Over 32% Following Earnings Release, Annual Loss Narrows by 87.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114135542","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114135542?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:51","pubTimestamp":1773021104,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its share price jump more than 32% after announcing its financial results. As of the latest update, the stock had risen by 32.48%, trading at HK$14.40 with a turnover of...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1585","BK1161","BK1587","02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618690704","title":"CARsgen Therapeutics Shares to Join Stock Connect Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2618690704","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618690704?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:33","pubTimestamp":1773020011,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics (HKG:2171) said its shares were eligible for inclusion in the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect programs, according to a Hong Kong bourse filing Monday.The inclusions are effective March 9.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK4007","BK1585","BK4539","LENZ","BK4139","BK1161","02171","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162431359","title":"Stock Track | CARSGEN-B Soars 15.00% Intraday on Inclusion in Stock Connect Southbound Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1162431359","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162431359?lang=en_us&edition=fundamental","pubTime":"2026-03-09 09:31","pubTimestamp":1773019900,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its stock price soar 15.00% during intraday trading on Monday, following the company's announcement that its shares have been added to the southbound eligible list of the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168644813","title":"CARSGEN-B (02171) Added to Southbound Stock Connect Eligibility List","url":"https://stock-news.laohu8.com/highlight/detail?id=1168644813","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168644813?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:24","pubTimestamp":1773015859,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that, according to the \"Notice on Adjustments to Southbound Securities under the Shanghai-Hong Kong Stock Connect\" and the \"Announcement on Adjustments to the List of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["161027","VXUS","VT","BK1161","02171","BK1585","BK1587","BK1574","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130305862","title":"CARSGEN-B (02171) Announces Inclusion in Southbound Stock Connect","url":"https://stock-news.laohu8.com/highlight/detail?id=1130305862","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130305862?lang=en_us&edition=fundamental","pubTime":"2026-03-09 08:02","pubTimestamp":1773014579,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Limited (CARSGEN-B, 02171) disclosed its inclusion in the Shanghai-Hong Kong Stock Connect and the Shenzhen-Hong Kong Stock Connect, effective March 9, 2026. According...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":-0.008},{"period":"1month","weight":0.5447},{"period":"3month","weight":0.5061},{"period":"6month","weight":0.5219},{"period":"1year","weight":0.5732},{"period":"ytd","weight":0.6633}],"compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0.0253},{"period":"3month","weight":-0.0288},{"period":"6month","weight":-0.007},{"period":"1year","weight":0.1857},{"period":"ytd","weight":0.0136}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company mainly operates its businesses in China and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07858},{"month":2,"riseRate":0.6,"avgChangeRate":0.230493},{"month":3,"riseRate":0.2,"avgChangeRate":-0.058535},{"month":4,"riseRate":0.4,"avgChangeRate":0.012432},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"CARSGEN-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARSGEN-B,02171,CARSGEN-B股票,CARSGEN-B股票老虎,CARSGEN-B股票老虎国际,CARSGEN-B行情,CARSGEN-B股票行情,CARSGEN-B股价,CARSGEN-B股市,CARSGEN-B股票价格,CARSGEN-B股票交易,CARSGEN-B股票购买,CARSGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}